Background Benzodiazepine misuse is a growing public health problem, with increases in
benzodiazepine-related overdose deaths and emergency room visits in recent years …

Abstract Background and Aims We aim to quantify the prevalence and risk of having a
cannabis use disorder (CUD), cannabis abuse (CA) or cannabis dependence (CD) among …

This paper summarises data for the prevalence, correlates, and probable adverse health
consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We …

The current article summarizes the results of a comprehensive review of the international
research published between 1990 and 2010. The research was focused on the prevalence …

Aims To examine changes in the evidence on the adverse health effects of cannabis since
1993. Methods A comparison of the evidence in 1993 with the evidence and interpretation of …

This paper summarizes the most probable of the adverse health effects of regular cannabis
use sustained over years, as indicated by epidemiological studies that have established an …

BACKGROUND:: To date, there have been no published data on 12-month comorbidity of
DSM-IV alcohol and drug use disorders in the general US population. The purposes of the …

The aim of this paper is to report the prevalence of 12-month comorbidity between DSM-IV
alcohol use disorders (abuse or dependence) and anxiety, affective and drug use disorders …

The Cannabis Use Disorders Identification Test (CUDIT) was used for the first time as part of
a randomized controlled trial for brief interventions in mild to moderate alcohol-dependent …

Background. The purpose of this study was to present 12-month and lifetime estimates of the
prevalence, sociodemographic and clinical correlates, and psychiatric co-morbidity of DSM …